-
Something wrong with this record ?
Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, K. Lalic, J. Skrha, P. Valensi, A. Ceriello,
Language English Country England, Great Britain
Document type Congress
NLK
BioMedCentral
from 2002-12-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-04-01
Medline Complete (EBSCOhost)
from 2002-04-08
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-12-01
- MeSH
- Biomedical Research methods MeSH
- Diabetes Mellitus diagnosis epidemiology therapy MeSH
- Cardiology methods MeSH
- Cardiovascular Diseases diagnosis epidemiology therapy MeSH
- Clinical Trials as Topic * MeSH
- Cooperative Behavior MeSH
- Humans MeSH
- Interdisciplinary Communication MeSH
- Patient Care Team MeSH
- Check Tag
- Humans MeSH
- Publication type
- Congress MeSH
The 3rd Cardiovascular Outcome Trial Summit of the Diabetes & Cardiovascular Disease EASD Study Group was held on the 26-27 October 2017 in Munich. As in 2015 and 2016, this summit was organised in light of recently completed and published CVOTs on diabetes, aiming to serve as a reference meeting for in-depth discussions on the topic. Amongst others, the CVOTs EXSCEL, DEVOTE, the CANVAS program and the ACE-trial, which released primary outcome results in 2017, were discussed. Trial implications for diabetes management and recent perspectives of diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners were highlighted. The clinical relevance of cardiovascular outcome trials and its implications regarding reimbursement were compared with real-world studies. The 4th Cardiovascular Outcome Trial Summit will be held in Munich 25-26 October 2018 ( http://www.dcvd.org ).
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012823
- 003
- CZ-PrNML
- 005
- 20190411094644.0
- 007
- ta
- 008
- 190405s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12933-018-0667-2 $2 doi
- 035 __
- $a (PubMed)29458368
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Schnell, Oliver $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, Neuherberg, 85764, Munich, Germany. oliver.schnell@lrz.uni-muenchen.de.
- 245 10
- $a Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group / $c O. Schnell, E. Standl, D. Catrinoiu, S. Genovese, N. Lalic, K. Lalic, J. Skrha, P. Valensi, A. Ceriello,
- 520 9_
- $a The 3rd Cardiovascular Outcome Trial Summit of the Diabetes & Cardiovascular Disease EASD Study Group was held on the 26-27 October 2017 in Munich. As in 2015 and 2016, this summit was organised in light of recently completed and published CVOTs on diabetes, aiming to serve as a reference meeting for in-depth discussions on the topic. Amongst others, the CVOTs EXSCEL, DEVOTE, the CANVAS program and the ACE-trial, which released primary outcome results in 2017, were discussed. Trial implications for diabetes management and recent perspectives of diabetologists, cardiologists, endocrinologists, nephrologists and general practitioners were highlighted. The clinical relevance of cardiovascular outcome trials and its implications regarding reimbursement were compared with real-world studies. The 4th Cardiovascular Outcome Trial Summit will be held in Munich 25-26 October 2018 ( http://www.dcvd.org ).
- 650 _2
- $a biomedicínský výzkum $x metody $7 D035843
- 650 _2
- $a kardiologie $x metody $7 D002309
- 650 _2
- $a kardiovaskulární nemoci $x diagnóza $x epidemiologie $x terapie $7 D002318
- 650 12
- $a klinické zkoušky jako téma $7 D002986
- 650 _2
- $a kooperační chování $7 D003299
- 650 _2
- $a diabetes mellitus $x diagnóza $x epidemiologie $x terapie $7 D003920
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mezioborová komunikace $7 D033183
- 650 _2
- $a týmová péče o pacienty $7 D010348
- 655 _2
- $a kongresy $7 D016423
- 700 1_
- $a Standl, Eberhard $u Forschergruppe Diabetes e.V., Munich, Ingolstaedter Landstrasse 1, Neuherberg, 85764, Munich, Germany.
- 700 1_
- $a Catrinoiu, Doina $u Internal Medicine Department, Clinical County Emergency Hospital Constanta, Tomis Blvd. No. 145, 900591, Constanta, Romania.
- 700 1_
- $a Genovese, Stefano $u Diabetes, Endocrine and Metabolic Disease Unit, IRCCS Centro Cardiologico Monzino, Via Carlo Parea 4, 20138, Milan, Italy.
- 700 1_
- $a Lalic, Nebojsa $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
- 700 1_
- $a Lalic, Katarina $u Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Dr Subotica 13, Belgrade, 11000, Serbia.
- 700 1_
- $a Skrha, Jan $u 3rd Department of Internal Medicine, Charles University, 1st Faculty of Medicine, U Nemocnice 1, Prague 2, 128 08, Czech Republic.
- 700 1_
- $a Valensi, Paul $u Department of Endocrinology Diabetology Nutrition, Paris 13 University, CINFO, CRNH-IdF, Jean VERDIER Hospital, Avenue du 14 Juillet, 93140, Bondy, France.
- 700 1_
- $a Ceriello, Antonio $u Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain. Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Via Milanese 300, 20099, Sesto San Giovanni, MI, Italy.
- 773 0_
- $w MED00008211 $t Cardiovascular diabetology $x 1475-2840 $g Roč. 17, č. 1 (2018), s. 30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29458368 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190411094701 $b ABA008
- 999 __
- $a ok $b bmc $g 1392133 $s 1051128
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 17 $c 1 $d 30 $e 20180219 $i 1475-2840 $m Cardiovascular diabetology $n Cardiovasc Diabetol $x MED00008211
- LZP __
- $a Pubmed-20190405